The stock of Oscar Health Inc. (NYSE:OSCR) increased by increased by $0.21 on Friday to finish at $17.00, up 1.25 percent. The last five days have seen an average of 1,641,580 shares of common stock traded. The average number of shares traded over the last 20 days was 1,582,240, while the average volume over the last 50 days totaled 1,773,946.
OSCR stock dropped -1.05% since last month. On 10/12/21, the company’s shares reached a one-month low of $13.83. The stock touched a high of $37.00, after rallying from a low of $12.06 in 52 weeks. The price of OSCR stock has declined by -51.15%. Still, the stock price is down -54.05% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
There have been 39 days since Oscar Health Inc. (OSCR) last reported insider trading activity on Sep 16. On Sep 16, Chief Executive Officer Schlosser Mario acquired 57,300 shares at $17.53 each. This transaction resulted in the insider spending $1,004,515. On Sep 15, Thrive Partners VII Growth GP, added 323,725 shares at a price of US$17.86. After the transaction, the insider now owns 4,755,222 shares. Co-Founder and Vice Chairman Kushner Joshua had earlier bought 323,725 shares on Sep 15 for $17.86 a share. The transaction was completed for $5,780,110.
Oscar Health Inc.’s operating margin stood at -26.30% for the same period.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. There was a 35.00% return on investment (ROI) in the past year. ROE has averaged 16.45 in the past year for the broader industry.
According to Oscar Health Inc.’s quarterly financial report for the quarter that ended June 29. Net income for the quarter came in at $529.28 million, while revenues rose by 100.0% to $369.39 million. It was predicted that Oscar Health Inc.’s quarterly earnings would be -$0.35, but it ended up being -$0.46, beating the consensus by 23.90%. Equity owned by shareholders amounts to $207.67 million.
Here’s a quick look at Oscar Health Inc.’s (OSCR) price momentum from a technical perspective. As of 22 October, the RSI 9-day stood at 61.05%, suggesting the stock is Neutral, with a 54.88% historical volatility rate.
The stochastic %K and %D were 65.89% and 48.38% respectively, while the average true range (ATR) was 0.99. Based on the 14-day stochastic reading of 91.35%, the RSI (14) reading is 56.18%. On the 9-day MACD Oscillator, the stock is at 1.11, and the 14-day reading is at 1.12.
In its analyst report released on September 10, 2021, Cowen began covering Oscar Health Inc. (NYSE: OSCR). The stock was rated as a Market perform by the brokerage firm. Analysts have assigned Oscar Health Inc. (OSCR) an Overweight rating. OSCR is a stock that is recommended for selling by 1 brokerage firm, while 1 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 4 others recommend it as a buy.
What is OSCR’s price target for the next 12 months?
The current consensus forecast for the stock is between $13.00 and $30.00, with a median target price of $26.00. In analyzing these forecasts, the average price target given by analysts for Oscar Health Inc. (OSCR) is $22.83.